Rabbit Polyclonal KLF12 antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 3 publications. Immunogen corresponding to Recombinant Fragment Protein within Human KLF12 aa 1-100.
View Alternative Names
AP2REP, HSPC122, KLF12, Krueppel-like factor 12, Transcriptional repressor AP-2rep
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-KLF12 antibody (AB221602)
PFA-fixed, Triton X-100 permeabilized SH-SY5Y (human neuroblastoma cell line from bone marrow) cells stained for KLF12 (green) using ab221602 at 4 μg/ml in ICC/IF.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
KLF12 influences cell differentiation proliferation and apoptosis. It operates as part of transcriptional complexes often interacting with co-regulators such as histone deacetylases. The protein controls the expression of critical genes involved in cellular growth and maintenance exerting broad impacts on cellular phenotype. KLF12's interaction with co-repressors alters chromatin structure influencing transcriptional landscapes.
Pathways
KLF12 regulates the Wnt signaling pathway which is significant for controlling cell fate and migration. KLF12 interacts with components like beta-catenin altering the pathway's output and affecting cellular responses to developmental signals. Additionally KLF12 is linked to the TGF-beta signaling pathway influencing related proteins and impacting cellular processes such as proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:2526 PubMed38514666
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer management and research 13:3789-3801 PubMed34007212
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 19:2475-2480 PubMed32194747
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com